TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Cytokinetics alleging false statements and misleading disclosures regarding its New Drug Application submission and FDA approval timeline for aficamten.

Insights
AAPL   negative

Stock declined by 0.93%, suggesting potential market challenges


CYTK   negative

The lawsuit alleges the company made materially false and misleading statements about its drug approval process, misrepresented NDA submission timeline, and failed to disclose critical regulatory risks, which suggests potential corporate misconduct